
Petros Constantine Karakousis MD
Professor of Medicine, Johns Hopkins University School of Medicine
Join to view full profile
1800 Orleans StreetBaltimore, MD 21287
Phone+1 410-955-5000
Fax+1 410-955-5001
Dr. Karakousis is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 2002 - 2005
University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
WashU MedicineClass of 1998
Johns Hopkins UniversityB.A., Summa Cum Laude, 1994
Certifications & Licensure
MD State Medical License 2005 - 2026
PA State Medical License 1999 - 2002
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Member American Society of Clinical Investigation, 2021
- American Society of Clinical Investigation 2021
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2016
Clinical Trials
- Statin Adjunctive Therapy for TB Start of enrollment: 2020 Mar 09
- StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis Start of enrollment: 2020 Feb 21
Publications & Presentations
PubMed
- A copper uptake ABC transport system is essential forvirulence.Zhihong Xu, Huang Tang, Meiyi Yan, Haifeng Li, Aiping Zhou
Emerging Microbes & Infections. 2026-12-01 - Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models.Styliani Karanika, Tianyin Wang, Addis Yilma, Jennie Ruelas Castillo, James T Gordy
The Journal of Clinical Investigation. 2026-04-01 - 1 citationsCholesterol efflux in HIV-associated atherosclerosis: mechanisms and targets.Emily Lu, Vignesh Chidambaram, Amudha Kumar, Hannah G Cotto Aparicio, Yasmeen Golzar
Trends in Molecular Medicine. 2026-02-01
Journal Articles
- Genome analysis of Mycobacterium avium subspecies hominissuis strain 109Matern WM, Bader JS, Karakousis PC, Sci Data, 1/1/2018
- Unprecedented in Vitro Antitubercular Activitiy of Manganese(II) Complexes Containing 1, 10-Phenanthroline and Dicarboxylate Ligands: Increased Activity, Superior Sele...McCarron P, McCann M, Devereux M, Kavanagh K, Skerry C, Karakousis PC, Aor AC, Mello TP, Santos ALS, Campos DL, Pavan FR, Front Microbiol, 1/1/2018
- Gene enrichment analysis reveals major regulators of Mycobacterium tuberculosis gene expression in two models of antibiotic toleranceMatern WM, Rifat D, Bader J, Karakousis PC, Front Microbiol, 1/1/2018
Books/Book Chapters
Lectures
- "Overview of Tuberculosis"1/1/2019
- "Animal models of TB infection."1/1/2019
- "Tuberculosis and Antimicrobials"JHUSOM (Johns Hopkins University School of Medicine), 2012-2019 - 1/1/2019
Other
- "XDR-TB Scare"Karakousis PC, Fox National News (11:00 AM, Thursday)
1/31/2007 - Greetings from sunny (most of the time) San Diego: Highlights from the 41st Annual Meeting of the Infectious Diseases Society of America.Karakousis PC, Page KR, Bishai WR, JHU (Johns Hopkins University)Antibiotic Guide Website
http://hopkins-abxguide.org
1/1/2003 - Synopsis of key presentations at the 40th Annual Meeting of IDSA (October 24-27, 2002, Chicago).Karakousis PC, Bishai WR, JHU (Johns Hopkins University)Antibiotic Guide Website
http://hopkins-abxguide.org
1/1/2002
Press Mentions
Why You Should Get Vaccinated Against COVID-19 if You Take StatinsNovember 2nd, 2021
Statins Not Beneficial for Preventing COVID-19 MortalityNovember 2nd, 2021
Do Cholesterol Drugs Reduce COVID Risks? Study Findings Are Conflicting. Here’s WhyOctober 27th, 2021
Grant Support
- Advancing Apoptosis-Inducing Agents as Host-Directed Therapy for TBJOHNS HOPKINS UNIVERSITY2025–2029
- JHU TRAC: Training and Supporting the Next Generation of TB ResearchersJOHNS HOPKINS UNIVERSITY2022–2027
- Characterizing CaeA-mediated rifampin tolerance in MTBJOHNS HOPKINS UNIVERSITY2022–2025
- Therapeutic vaccination to augment stringent response-specific T-cell immunity to MTB persistersJOHNS HOPKINS UNIVERSITY2020–2025
- Mentoring in Immunometabolic Dysregulation in TB and TB/HIVJOHNS HOPKINS UNIVERSITY2019–2025
Other Languages
- Greek, Spanish, German, Russian
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/petros-karakousis
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









